FingerprintDive into the research topics of 'Initial testing (stage 1) of tazemetostat (EPZ-6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program'. Together they form a unique fingerprint.
- Sort by
Raushan T. Kurmasheva, Melissa Sammons, Edward Favours, Jianwrong Wu, Dias Kurmashev, Katherine Cosmopoulos, Heike Keilhack, Christine R. Klaus, Peter J. Houghton, Malcolm A. Smith
Research output: Contribution to journal › Article › peer-review